EIA COVID-19 NP IgM
Manufactured by TestLine Clinical Diagnostics s.r.o., Czechia - www.testlinecd.com/
Device identification number
1102
CE Marking
✓Yes
HSC common list
×No
HSC mutual recognition
×No
Format
Automated, Manual
Target
Antibody, IgM
Specimen
Plasma, Serum
Commercial Status
Commercialised
Last Update
2021-05-10 01:04:00 CET
Comments
https://www.testlinecd.com/eia-covid-19-np-igm
Assay Type
Immuno-Antibody
Reader Required
Yes
Method
Immunoassay
Measurement
Semiquantitative
Time
90 minutes
Subclass
Fluorescence
Clinical Sensitivity
95.65 %
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements